We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
+16.16%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$179M
AUM Growth
+$7.38M
Cap. Flow
-$6.1M
Cap. Flow %
-3.41%
Top 10 Hldgs %
57.08%
Holding
70
New
27
Increased
8
Reduced
10
Closed
24

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$11.5M
2
BIIB icon
Biogen
BIIB
+$7.82M
3
PBYI icon
Puma Biotechnology
PBYI
+$5.84M
4
TMO icon
Thermo Fisher Scientific
TMO
+$4.59M
5
GSK icon
GSK
GSK
+$3.28M

Top Sells

Rank Stock Value
1
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$5.98M
2
EW icon
Edwards Lifesciences
EW
+$5.15M
3
ZBH icon
Zimmer Biomet
ZBH
+$4.82M
4
ACRS icon
Aclaris Therapeutics
ACRS
+$3.76M
5
NTUS
Natus Medical Inc
NTUS
+$3.16M

Sector Composition

Rank Sector Weight
1 Healthcare 64.1%
2 Industrials 3.12%
3 Financials 2.65%
4 Technology 0.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCXI
26
DELISTED
ChemoCentryx, Inc.
CCXI
$2.14M 1.2%
294,150
-31,100
-10% -$224K
VRTX icon
27
Vertex Pharmaceuticals
VRTX
$123B
$2.13M 1.19%
+19,475
New +$1.71M
GMED icon
28
Globus Medical
GMED
$10.9B
$1.78M 0.99%
+60,000
New +$1.64M
IQV icon
29
PUT
IQVIA
IQV
$40B
$1.73M 0.97%
+21,500
New +$1.68M
INSM icon
30
PUT
Insmed
INSM
$22.7B
$1.49M 0.83%
+85,000
New +$1.31M
RCKT icon
31
Rocket Pharmaceuticals
RCKT
$346M
$1.45M 0.81%
+181,725
New +$1.22M
CHRS icon
32
Coherus Oncology
CHRS
$224M
$1.35M 0.75%
+63,800
New +$1.57M
VIRX
33
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.28M 0.72%
+8,912
New +$1.27M
SYRE icon
34
Spyre Therapeutics
SYRE
$8.28B
$1.27M 0.71%
6,796
-743
-10% -$105K
VCRA
35
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$1.24M 0.69%
+49,871
New +$1.06M
CERN
36
PUT
DELISTED
Cerner Corp
CERN
$1.18M 0.66%
20,000
-129,200
-87% -$6.98M
MZOR
37
DELISTED
Mazor Robotics Ltd.
MZOR
$937K 0.52%
+31,465
New +$741K
AVDL
38
DELISTED
Avadel Pharmaceuticals
AVDL
$885K 0.5%
91,413
– –
AXSM icon
39
Axsome Therapeutics
AXSM
$12.3B
$819K 0.46%
+210,000
New +$1M
ALNY icon
40
PUT
Alnylam Pharmaceuticals
ALNY
$38.2B
$692K 0.39%
+13,500
New +$624K
LUMO
41
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$613K 0.34%
+2,824
New +$403K
PFNX
42
DELISTED
Pfenex Inc.
PFNX
$499K 0.28%
+85,867
New +$646K
OASM
43
DELISTED
Oasmia Pharmaceutical AB
OASM
$377K 0.21%
197,470
+15,200
+8% +$35.6K
FWP
44
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$306K 0.17%
2,032
-5,289
-72% -$996K
TMBR
45
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$158K 0.09%
21
-55
-72% -$381K
ANTH
46
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$142K 0.08%
+41,714
New +$197K
ACAD icon
47
PUT
Acadia Pharmaceuticals
ACAD
$4.4B
– –
-563,200
Closed -$16.2M
ACRS icon
48
Aclaris Therapeutics
ACRS
$739M
– –
-138,441
Closed -$3.76M
AMGN icon
49
CALL
Amgen
AMGN
$212B
– –
-20,000
Closed -$2.92M
AMGN icon
50
Amgen
AMGN
$212B
– –
-16,430
Closed -$2.4M
1
2
3

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Sio Capital Management held 70 positions worth $179M, up 4.3% from $171M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Sio Capital Management withdrew a net $6.1M in Q1 2017, closing 24 positions and reducing 10 holdings. Its most notable exit was HILL-ROM HOLDINGS, INC., an estimated $5.98M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 44% a quarter earlier, followed by Industrials and Financials.

Against the trend, Sio Capital Management opened a new position in Sanofi worth $12.2M.

  • Sio Capital Management's largest Q1 2017 buy was Sanofi: 270,422 shares worth $12.2M.
  • Sio Capital Management added most to GSK in Q1 2017, an estimated $3.28M increase.
  • Sio Capital Management's biggest Q1 2017 reduction was Advanced Accelerator Applications S.A., cutting an estimated $1.55M.
  • Sio Capital Management fully exited HILL-ROM HOLDINGS, INC. in Q1 2017, selling an estimated $5.98M.
  • Sio Capital Management's ten largest holdings make up 57% of its $179M portfolio in Q1 2017.
  • Sio Capital Management opened 27 new positions and closed 24 in Q1 2017.
  • Sio Capital Management's portfolio value rose 4.3% quarter-over-quarter to $179M.

Based on Sio Capital Management's 13F filing for Q1 2017, filed 15 May 2017.